Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ola Adebayo"'
Autor:
Jennifer Sun, Chaelee Park, Nicole Guenthner, Shannon Gurley, Luna Zhang, Berit Lubben, Ola Adebayo, Hannah Bash, Yixuan Chen, Mina Maksimos, Barbara Muz, Abdel Kareem Azab
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/72bd99275a284a2faf3865116dcc4f48
Publikováno v:
Leukemia Research Reports, Vol 16, Iss , Pp 100268- (2021)
CD47 is a surface glycoprotein expressed by host cells to impede phagocytosis upon binding to macrophage SIRPα, thereby represents an immune checkpoint known as the “don't-eat-me” signal. However, accumulating evidence shows that solid and hemat
Externí odkaz:
https://doaj.org/article/70e540e717574752be375e74aea525ef
Autor:
Chaelee Park, Barbara Muz, Ola Adebayo, Kinan Alhallak, Berit Lubben, John F. DiPersio, Hannah Bash, Jessica Yavner, Abdel Kareem Azab, Jennifer Sun, Samuel Achilefu, Amanda Jeske
Publikováno v:
Oncotarget
Acute myeloid leukemia (AML) is the most common type of leukemia and has a 5-year survival rate of 25%. The standard-of-care for AML has not changed in the past few decades. Promising immunotherapy options are being developed for the treatment of AML
Autor:
Jennifer Sun, Barbara Muz, Katerina Miari, Kinan Alhallak, Chaelee Park, Mina Maksimos, Berit Lubben, Yixuan Chen, Ola Adebayo, Hannah Bash, Sarah Kelly, Mark Fiala, Mark Williams, Diane Bender, Monica Shokeen, Ravi Vij, Abdel Kareem Azab
Multiple myeloma (MM) is the cancer of plasma cells within the bone marrow (BM) and remains incurable. Tumor-associated macrophages (TAMs) within the tumor microenvironment often display a pro-tumor phenotype and correlate with tumor proliferation, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7963044fb963f0410571115dcf309c70
https://doi.org/10.21203/rs.3.rs-2073669/v1
https://doi.org/10.21203/rs.3.rs-2073669/v1
Autor:
Berit Lubben, Kinan Alhallak, Jennifer Sun, Barbara Muz, Hannah Bash, Chaelee Park, Ola Adebayo, Samuel Achilefu, John F. DiPersio, Abdel K. Azab
Publikováno v:
The FASEB Journal. 36
Publikováno v:
Leukemia Research Reports, Vol 16, Iss, Pp 100268-(2021)
Leukemia Research Reports
Leukemia Research Reports
CD47 is a surface glycoprotein expressed by host cells to impede phagocytosis upon binding to macrophage SIRPα, thereby represents an immune checkpoint known as the "don't-eat-me" signal. However, accumulating evidence shows that solid and hematolog
Autor:
Kinan Alhallak, Hannah Bash, Ola Adebayo, Abdel Kareem Azab, Jessica Yavner, Ayah Khaskiah, Amanda Jeske, Chaelee Park, Jennifer Sun, Berit Lubben
Publikováno v:
Cancers, Vol 13, Iss 2853, p 2853 (2021)
Cancers
Cancers
Simple Summary Here we list the benefits and disadvantages of using bispecific T cell engagers (BTCEs) for the treatment of multiple myeloma (MM). We summarize the mechanism of action; the various targets used for BTCE therapy for MM such as BCMA, CD
Autor:
G. K. Jenyo, Ola Adebayo
Publikováno v:
American Journal of Humanities and Social Sciences. 1